Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer

ανά Santoro, Ana B, Vargens, Daniela D, Barros Filho, Mateus de Camargo, Bulzico, Daniel A, Kowalski, Luiz Paulo, Meirelles, Ricardo M R, Paula, Daniela P, Neves, Ronaldo R S, Pessoa, Cencita N, Struchine, Claudio J, Suarez-Kurtz, Guilherme
Τόπος έκδοσης Br J Clin Pharmacol (2014)